Sofia Straudi
Ferrara, Emilia-Romagna, 44124, Italy
NCT Number: NCT04622189
The purpose of this study is to assess the changes in physiological parameters and clinical scales resulting from treatment with AOT (action observation training) in subjects with subacute stroke. Furthermore, this study assess the perception of applicability and satisfaction degree for this kind of treatments.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ferrara, Emilia-Romagna, 44124, Italy
After being informed about the study, all patients give written informed consent and will undergo a 1-week screening period to determine eligibility for study entry. Patient who meet the eligibility requirements will be given clinical and instrumental assessments before the start of treatment (T0) after 3 weeks (T1), at the end of the treatment (T2) and after 6 months (T3). A training program of 4 weeks including 250 videos of every day actions has been developed. Videos includes transitive and intransitive actions. Each week has a five day program, each day is divided in three sessions, in each session there are observation and imitation and attentional questions. AOT is always performed in conjunction with the conventional rehabilitation program.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Integration of four main tools:
Time frame: Baseline, week 3, week 4, after 6 months
Scale that assess the sensorimotor impairment in individuals who have had stroke.
Time frame: Baseline, week 3, week 4,after 6 months
Scale that measures disability or dependence in activities of daily living in stroke patients.
Time frame: Baseline, week 3, week 4,after 6 months
To assess unilateral gross manual dexterity
Time frame: Baseline, week 3, week 4,after 6 months
To measure spasticity. It consists of a 5-point nominal scale using subjective clinical assessments of tone ranging from 0 - 'No increases in tone' to 4 - 'Limb rigid in flexion or extension [abduction/adduction]'. An additional grade is added (1+) for the MAS to indicate resistance in the movement.
Time frame: Baseline , week 3, week 4,after 6 months
Scale that consists of a straight line with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be'. The length of the line is 10-cm. Measurements from the starting point (left end) of the scale to the patients' marks are recorded in centimeters and are interpreted as their pain.
Time frame: Up to 1 month
EEG data will be recorded to test presence of particular changes in brain activity in during AOT training. In particular plasticity and mu rhythm desynchronization will be investigated.
Time frame: Up to 1 month
Kinematic data of trunk and affected hand will be recorded during subject imitations and will be analysed to assess any improvements.
Time frame: Baseline and week 4
is a stroke-specific cognitive screen
Time frame: At week 4
self-report questionnaire using a 5 point Likert scale (1 - Strongly disagree; 5 - Strongly agree). Higher score indicates greater satisfaction with the treatment.
University Hospital of Ferrara
Other
Neuro-rehabilitation of Upper Limb Stroke Patients Through Motor Resonance and Mirror Neurons
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07698639
Brain Diseases, Cardiovascular Diseases
Samara, Samara Oblast, Russia
View Trial DetailsNCT06965894
Brain Diseases, Cardiovascular Diseases
Jounieh, Keserwan, Lebanon
View Trial DetailsNCT07617207
Brain Diseases, Cardiovascular Diseases
Manila, National Capital Region, Philippines
View Trial DetailsNCT07359001
Brain Diseases, Cardiovascular Diseases
Seoul, South Korea
View Trial Details